Skip to main content
. 2020 Sep 11;10:1785. doi: 10.3389/fonc.2020.01785

TABLE 3.

Management of CIP.

Grades Guideline for the management
G1 • Consider holding ICIs Monitor symptoms every 2–3 days
• May offer one repeat CT in 3–4 weeks
• In patients who have had baseline testing, may offer a repeat spirometry/DLCO in 3–4 weeks
○ If improvement is observed, continue to follow up
○ If condition worsens, treat as G2 or 3–4
G2 • Hold ICIs until resolution to G1 or less
• Consider infectious workup: nasal swab for potential viral pathogens sputum culture, blood culture, and urine culture
• Consider chest CT with contrast Repeat chest CT in 3–4 weeks
• Consider empirical antibiotics if infection has not yet been fully excluded
• Prednisone IV 1–2 mg/kg/day
○ If improvement is observed, start slow steroid taper by 5 to 10 mg/week over 4 to 6 weeks
○ If condition worsens, treat as G3–4
G3/G4 • Permanently discontinue ICIs
• Pulmonary consultation for bronchoscopy with BAL
  Consider biopsies for atypical lesions Methylprednisolone IV 2–4 mg/kg/day
○ If improvement is observed, taper corticosteroids over 4–6 weeks
○ If not improving or worsening after 48 h: add infliximab IV 5 mg/kg
  or MMF IV 1 g BID
  or IVIG for 5 days
  or cyclophosphamide

ICIs, immune checkpoint inhibitors; CT, computed tomography; DLCO, carbon monoxide diffusing capacity; IV, intravenous; BAL, bronchoalveolar lavage; MMF, mycophenolate mofetil; BID, two times daily; and IVIG, intravenous immunoglobulin.